‘Prolor Biotech’: Positive Results In Hemophilia Drug Trial
Prolor Biotech Inc. reported positive results in a study of its new version of the hemophilia drug Factor VIIa-CTP in a pre-clinical trial on mice. The study showed that mice which received the longer-acting version of the drug showed a higher survival and recovery rate over a longer period of time, compared to those that […]
February 16, 2012
‘Tiltan Pharma’ Starts Phase II Trial For Pancreatic Cancer Drug
Tiltan Pharma Ltd. announced it has started phase II of its clinical trial for its new drug for pancreatic cancer, following approval by the Israeli Ministry of Health. The drug is designed to prevent blood flow to tumors and prevent their growth. The second phase of the trial will include 80 patients: 40 with newly […]
February 16, 2012
Smartphone App ‘Viber’ Reaches 50M Users
Viber Media Inc. announced today that it has reached over 50 million users since its launch 13 months ago. The company developed a mobile app for smartphones that allows its users to make phone calls and send text messages for free. Viber users are making over a billion minutes worth of calls and sending nearly a […]
February 15, 2012